The influence of angle of cervical cancer’s applicators on dosimetry and positions of reference points and critical organs
Main Article Content
Abstract
The clamps used for fixation of the applicators for high-dose-rate intracavitary brachytherapy of carcinoma of the cervix during treatment time can adjust the applicators’ angle away from critical organs, bladder and rectum, to reduce radiation dose to these organs additional to gauze’s packing. However, such adjustment can vary the positions of reference points and also critical organs. Objective: To study the influence of applicators’ angle on bladder and rectal doses and positional variations of reference points including critical organs. Materials and Method: Fifty pairs of orthogonal radiographs using reconstruction jig, before and after adjustment of applicators’ angle, of 50 applications for 29 patients with cervical cancer which were inserted with both tandem and ovoids were reviewed. Treatment plannings were performed with the BrachyVision version 7.3.10 software. Prescribed dose at point A was 6 Grays (Gy), without dwell time optimization. Variations of maximum bladder and rectal doses influenced by angle’s adjustments were statistically tested by Wilcoxon matched pair test. The displacement of reference points and changes of distance between nearby organs were studied using the vector analysis. The correlations of the changes of applicators’ angle with positional variations of reference points and the changes of distance between organs were analysed with Spearman’s rho test. Results: The averaged change of applicators’ angle was 7.81±4.08 degree and it resulted the significant variations of maximum bladder and rectal dose (both p<0.001) with mean+ SD of 39.78±36.20 cGy for bladder and 38.00±31.28 cGy for rectum. The correlation with the change of applicators’angle of the variation of maximum bladder dose was more than that of maximum rectal dose with correlation coelticients of 0.751 for bladder and 0.575 for rectum. The averaged displacement of cervical os, point A, B and cervix were 0.62±0.31, 0.89±0.44, 0.88±0.45 and 0.76±0.38) cm, respectively. The averaged changes in distance from bladder to rectum, cervical os to bladder and cervical os to rectum were 0.11±0.09, 0.13±0.11 and 0.17±0.10 cm, respectively. The variations of positions of reference points correlated with the changes of applicators’ angles more than those of the distances between organs (Correlation coeltients were 0.867, 0.941, 0.926 and 0.918 for cervical os, point A, B and cervix, respectively, and were 0.561, 0.600 and 0.631 for bladder to rectum, cervical os to bladder and cervical os to rectum, respectively). Conclusion: The applicators’ angle significantly influenced on the maximum bladder and rectal doses resulted from positional variations of points of prescribed dose. All of positional variations of reference points increased with the change of applicators’ angle. All nearby organs were moved together with the cervical os with direction of applicators’ angle adjustment but less affected than positions of reference points. However, the averaged positional variations of reference points were not more than those in the previous researches which studied in multiple applications of same patients.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Hoskin PJ, Cook M, Bouscale D, Cansdale J. Changes in applicator position with fractionated high dose rate gynecology brachytherapy. Radiother Oncol 1996; 40: 59-62.
Datta NR, Kumar S, Das KJ, Pandy CM, Halder S, Ayyagari S. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38. Radiother Oncol 2001; 60: 15-24.
Wulf J, Popp K, Oppitz U, Baier K, Flentje M. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer: analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions. Strahlenther Onkol 2004; 180: 216-24.
Datta NR, Basu R, Das KJ, Rajasekar D, Pandy CM, Singh U, et al. Problems and uncertainties with multiple point A’s during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix. Clin Oncol 2004; 16: 129-37.
Garipagaoglu M, Tuncel N, Dalmaz MG, Gulkesen H, Toy A, Kizilda AU, et al. Changes in applicator positions and dose distribution between high dose rate brachytherapy fractions in cervix carcinoma patients receiving definitive radiotherapy. Br J Radiol 2006; 79: 504-9.
Elhanafy OA, Das RK, Paliwal BR, Migahed MD, Sakr HA, Elleithy M. Anatomic variation of prescription points and treatment volume with fractionated high-dose-rate gynecological brachytherapy. J Appl Clin Med Phys 2002; 3: 1-5.
Grigsby PW, Georgiou A, Williamson JF, Perez CA. Anatomic variation of gynecologic brachytherapy prescription points. Int J Radiat Oncol Biol Phys 1993; 27: 725-9.
Kim RY, Meyer JT, Plott WE, Spencer SA, Meredith RF, Jennelle RLS, et al. Major geometric variations between multiple high-dose rate applications of brachytherapy in cancer of the cervix: frequency and types of variation. Ther Radiol 1995; 195: 419-22.
Hoskin PJ, Bownes P, Summers A. The influence of applicator angle on dosimetry in vaginal vault brachytherapy. Br J Radiol 2002; 75: 234-7.
Yun HG, Shin KC. Study of patient’s position to reduce late complications in high dose rate intracavitary radiation of the uterine cervix cancer. J Korean Soc Ther Radiol Oncol 1998; 16: 477-84.
Senkus-Konefka E, Kobierska A, Jassem J, Serkies K, Badzio A. Influence of brachytherapy applicators geometry on dose distribution in cervical cancer. Strahlenther Onkol 1997; 173: 323-9.
Eng TY, Fuller CD, Cavanaugh SX, Blough MM, Sadeghi A, Herman T. Significant rectal and bladder dose reduction via utilization of Foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervix. Int J Radiat Oncol Biol Phys 2004; 59: 174-8.
Thomadsen BR, Shahabi S, Stitt JA, Buchler DA, Fowler JF, Paliwal BR, et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II, procedural and physical considerations. Int J Radiat Oncol Bio Phys 1992; 24: 349-57.
Rutten RR, Lawyer AA, Berner P. Dose variation due to differences in applicator placement used for intracavitary brachytherapy of cervical cancer. Med Dosim 1998; 23: 57-63.
Pham HT, Chen Y, Rouby E, Lustig RA, Wallner PE. Changes in high-dose-rate tandem and ovoid applicator positions during treatment in an unfixed brachytherapy system. Radiology 1998; 206: 525-31.